Skip to main content
. 2023 Sep 28;29(3):e309–e318. doi: 10.1093/oncolo/oyad275

Table 2.

Clinicopathological characteristics associated with pCR.

Characteristics Total non-pCR
N (%)
pCR
N (%)
Univariate analysis Multivariate analysis
χ2 P-value OR 95% CI P-value
Age at diagnosis 1.118 .290
 ≤55 430 270 (77.4) 160 (81.2)
 >55 116 79 (22.6) 37 (18.8)
Menopausal status 0.257 .612
 Premenopausal 336 212 (60.7) 124 (62.9)
 Postmenopausal 210 137 (39.3) 73 (37.1)
Family history 0.001 .977
 No 532 340 (97.4) 192 (97.5)
 Yes 14 9 (2.6) 5 (2.5)
T stage 7.963 .019 .028
 T1 43 23 (6.6) 20 (10.1) Reference
 T2 409 255 (73.1) 154 (78.2) 0.558 0.271-1.152 .115
 T3 + T4 94 71 (20.3) 23 (11.7) 0.317 0.134-0.752 .009
N stage 19.589 <.001 .002
 N0 143 79 (22.6) 64 (32.5) Reference
 N1 258 156 (44.7) 102 (51.8) 0.814 0.513-1.293 .383
 N2 + N3 145 114 (32.7) 31 (15.7) 0.371 0.209-0.657 .001
AR status 10.631 .001
 <1% 318 187(61.5) 131 (76.2) Reference
 ≥1% 158 117 (38.5) 41 (23.8) 0.546 0.354-0.843 .006
Ki-67 index 3.598 .058
 ≤30% 37 29 (8.3) 8 (4.1) Reference
 >30% 509 320 (91.7) 189 (95.9) 2.135 0.834-5.464 .114
Basal-like phenotype 0.007 .933
 No 22 14 (4.3) 8 (4.5)
 Yes 479 309 (95.7) 170 (95.5)
HER2 status 0.359 .549
 0 254 159 (45.6) 95 (48.2)
 Low 292 190 (54.4) 102 (51.8)
HER2 status 0.405 .524
 0/1+ 405 262 (75.1) 143 (72.6)
 2+ and FISH- 141 87 (24.9) 54 (27.4)
HER2 status 1.699 .428
 0 254 159 (45.6) 95 (48.2)
 1+ 151 103 (29.5) 48 (24.4)
 2+and FISH- 141 87 (24.9) 54 (27.4)

Abbreviations: pCR: pathological complete response; AR: androgen receptor; HER2: human epidermal growth factor receptor 2; IHC: immunohistochemistry; FISH: fluorescence in situ hybridization.